electroCore (ECOR) EBITDA Margin Growth (3y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -343.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 17.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -178.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 487.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -283.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 72.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1,505.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -184.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -3,846.00 |
| 10 | electroCore | 92,394.96 | -8.79 Mn | 8.36 Mn | 16,745.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16,745.00 |
| Dec 31, 2025 | 19,931.00 |
| Sep 30, 2025 | 24,798.00 |
| Jun 30, 2025 | 22,232.00 |
| Mar 31, 2025 | 23,701.00 |
| Dec 31, 2024 | 32,342.00 |
| Sep 30, 2024 | 22,754.00 |
| Jun 30, 2024 | 36,772.00 |
| Mar 31, 2024 | 37,646.00 |
| Dec 31, 2023 | 60,494.00 |
| Sep 30, 2023 | 32,376.00 |
| Jun 30, 2023 | 64,623.00 |
| Mar 31, 2023 | 86,914.00 |
| Dec 31, 2022 | 104,385.00 |
| Sep 30, 2022 | 131,383.00 |
| Jun 30, 2022 | 171,814.00 |
| Mar 31, 2022 | 317,559.00 |
| Dec 31, 2021 | 389,414.00 |
| Sep 30, 2021 | 870,843.00 |
| Jun 30, 2021 | 371,532.00 |
| Mar 31, 2021 | 1.08 Mn |
| Dec 31, 2020 | 251,753.00 |
| Sep 30, 2020 | 170,061.00 |
| Jun 30, 2020 | 341,161.00 |